# Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

> **NCT01523873** · — · COMPLETED · sponsor: **Guerbet** · enrollment: 35921 (actual)

## Conditions studied

- General Safety Profile of DOTAREM

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01523873
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 35921 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523873, "Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01523873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
